Monash IVF Group Limited: Business Overview, Financials & Competitive Analysis
Monash IVF Group Limited scores 7/10 on the AskCyborg Cyborg Score (Strong). Established fertility provider with defensive growth characteristics and strong dividend yield, positioned to benefit from demographic trends supporting fertility services demand. Monash IVF demonstrates strong market positioning as Australia's leading fertility provider with diversified revenue streams across ARS and ultrasound services. Consistent dividend payments (8.52% yield) and stable.
What is Monash IVF Group Limited's industry? Monash IVF Group Limited (monashivfgroup.com.au) operates in Healthcare - Assisted Reproductive Services & Diagnostics. AskCyborg classifies Monash IVF Group Limited under Healthcare - Assisted Reproductive Services & Diagnostics in its company registry.
Monash IVF Group is a provider of fertility services, specializing in Assisted Reproductive Services (ARS) and genetic care across Australia and South East Asia. The company offers fertility treatments and specialist ...
Cyborg Score thesis
Established fertility provider with defensive growth characteristics and strong dividend yield, positioned to benefit from...
Read the full analyst-debate transcript →Get the Latest Monash IVF Group Limited Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeMonash IVF Group Limited Overview
Pro stress-test →Monash IVF Group is a provider of fertility services, specializing in Assisted Reproductive Services (ARS) and genetic care across Australia and South East Asia. The company offers fertility treatments and specialist diagnostic obstetric and gynaecological ultrasound services. The company represents Australia's leading fertility and reproductive health provider with established operations in multiple jurisdictions.
Strategic Profile
Pro stress-test →The Group operates two main segments: Australia IVF and Ultrasound, which offer ARS, ultrasound, and related women's health services, and International IVF, which provides assisted reproductive care in South East Asia. The majority of revenue is generated from the Australian segment through its brands such as Fertility Solutions, KL Fertility, Monash IVF, Repromed, and others. This portfolio approach provides revenue diversification while maintaining market leadership in core fertility services.
Competitive Landscape
Pro stress-test →Monash IVF operates in the specialized fertility services sector with limited direct competitors in Australia due to regulatory barriers and capital intensity of establishing ARS clinics. Primary competition comes from other large fertility clinic networks and international operators seeking entry into Australian and Southeast Asian markets. The company's extensive clinic network and brand portfolio provide significant competitive moat.
Industry Context
Monash IVF Group Limited operates in Healthcare - Assisted Reproductive Services & Diagnostics.
Key facts
Founded: 2014 · Headquarters: Richmond, Victoria, Australia · Employees: 892 · Market cap: $330M AUD